Delayed
Nasdaq Stockholm
07:59:43 2023-11-03 am EDT
|
5-day change
|
1st Jan Change
|
0.1604
SEK
|
-1.11%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
814.2
|
674.3
|
553.4
|
310
|
374.4
|
181.7
|
181.7
|
Enterprise Value (EV)
1 |
814.2
|
646.8
|
417.9
|
254.1
|
374.4
|
392.5
|
439.6
|
P/E ratio
|
-5.81
x
|
-4.17
x
|
-3.39
x
|
-2.06
x
|
-0.91
x
|
-0.13
x
|
-0.43
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
136
x
|
127
x
|
74.8
x
|
13.8
x
|
9.36
x
|
1.1
x
|
0.73
x
|
EV / Revenue
|
136
x
|
122
x
|
56.5
x
|
11.3
x
|
9.36
x
|
2.38
x
|
1.77
x
|
EV / EBITDA
|
-6.02
x
|
-4.66
x
|
-3.54
x
|
-2.12
x
|
-2.47
x
|
-4.69
x
|
-42.4
x
|
EV / FCF
|
-
|
-3,838,817
x
|
-3,128,738
x
|
-1,938,041
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
5.13
x
|
3.04
x
|
2.53
x
|
-
|
-0.09
x
|
-0.07
x
|
Nbr of stocks (in thousands)
|
24,018
|
28,818
|
66,281
|
79,481
|
794,813
|
1,133,078
|
1,133,078
|
Reference price
2 |
33.90
|
23.40
|
8.350
|
3.900
|
0.4710
|
0.1604
|
0.1604
|
Announcement Date
|
2/14/19
|
2/14/20
|
2/16/21
|
2/16/22
|
2/16/23
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
6
|
5.3
|
7.4
|
22.4
|
40
|
165
|
248.5
|
EBITDA
1 |
-135.2
|
-138.9
|
-118
|
-119.7
|
-151.7
|
-83.63
|
-10.36
|
EBIT
1 |
-
|
-151.5
|
-134.3
|
-136.5
|
-168.1
|
-101.7
|
-30.16
|
Operating Margin
|
-
|
-2,858.49%
|
-1,814.86%
|
-609.38%
|
-420.25%
|
-61.61%
|
-12.14%
|
Earnings before Tax (EBT)
1 |
-
|
-151.1
|
-135.9
|
-136.3
|
-166.6
|
-101.2
|
-29.66
|
Net income
1 |
-
|
-151.1
|
-135.9
|
-136.3
|
-166.6
|
-101.2
|
-29.66
|
Net margin
|
-
|
-2,850.94%
|
-1,836.49%
|
-608.48%
|
-416.5%
|
-61.31%
|
-11.93%
|
EPS
2 |
-5.830
|
-5.610
|
-2.460
|
-1.890
|
-0.5200
|
-1.270
|
-0.3700
|
Free Cash Flow
|
-
|
-168.5
|
-133.6
|
-131.1
|
-
|
-
|
-
|
FCF margin
|
-
|
-3,179.25%
|
-1,805.07%
|
-585.27%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/14/19
|
2/14/20
|
2/16/21
|
2/16/22
|
2/16/23
|
-
|
-
|
Fiscal Period: December |
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
---|
Net sales
1 |
4
|
5.1
|
6.1
|
7.2
|
8.6
|
9.7
|
11
|
10.6
|
11.2
|
10.3
|
EBITDA
|
-34.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-39.3
|
-
|
-27
|
-43.5
|
-33.7
|
-35.8
|
-51.9
|
-46.7
|
-59.2
|
-40.5
|
Operating Margin
|
-982.5%
|
-
|
-442.62%
|
-604.17%
|
-391.86%
|
-369.07%
|
-471.82%
|
-440.57%
|
-528.57%
|
-393.2%
|
Earnings before Tax (EBT)
|
-38.8
|
-27.1
|
-26.9
|
-43.4
|
-33.3
|
-36.9
|
-
|
-
|
-
|
-
|
Net income
|
-38.8
|
-
|
-26.9
|
-43.4
|
-33.3
|
-36.9
|
-
|
-
|
-
|
-
|
Net margin
|
-970%
|
-
|
-440.98%
|
-602.78%
|
-387.21%
|
-380.41%
|
-
|
-
|
-
|
-
|
EPS
|
-0.5900
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
5/4/21
|
8/26/21
|
11/9/21
|
2/16/22
|
4/27/22
|
7/22/22
|
11/10/22
|
2/16/23
|
5/17/23
|
8/4/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
211
|
258
|
Net Cash position
1 |
-
|
27.5
|
136
|
55.9
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-2.52
x
|
-24.89
x
|
Free Cash Flow
|
-
|
-169
|
-134
|
-131
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-95.7%
|
-86.6%
|
-92.7%
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
4.560
|
2.750
|
1.540
|
-
|
-1.770
|
-2.150
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.5
|
0.6
|
0.88
|
0.6
|
-
|
1.65
|
2.49
|
Capex / Sales
|
8.33%
|
11.32%
|
11.92%
|
2.68%
|
-
|
1%
|
1%
|
Announcement Date
|
2/14/19
|
2/14/20
|
2/16/21
|
2/16/22
|
2/16/23
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -.--% | 16.63M | | +13.16% | 129B | | -9.23% | 10.77B | | +3.60% | 9.05B | | +19.75% | 7.38B | | +22.28% | 4.88B | | +7.55% | 3.41B | | -0.21% | 3.07B | | -4.80% | 2.24B | | -4.72% | 2.12B |
Medical Devices & Implants
|